Valuation — not yet established
No valuation for Strata Oncology is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($139.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Strata Oncology
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Debt | $6.1M | ▮ | ▮ |
| Oct 2020 | Debt | $5.0M | ▮ | ▮ |
| Apr 2018 | Early Stage VC | $11.8M | ▮ | ▮ |
| Feb 2016 | Early Stage VC | $6.3M | ▮ | ▮ |
How Strata Oncology's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Strata Oncology, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Strata Oncology raised?
- Strata Oncology has raised $139.2M in total funding across 4 recorded rounds.
- When did Strata Oncology last raise?
- Strata Oncology last raised in Nov 2024 (Debt), raising $6.1M.